Intended for healthcare professionals

News Exclusive Investigation

FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway

BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1898 (Published 30 July 2021) Cite this as: BMJ 2021;374:n1898